Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events

By J. Eikelboom, J. Hirsh, J. Weitz, M. Johnston, Q. Yi, S. Yusuf. Circulation, 2002

1,078 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Pharmacology

View Paper: https://www.semanticscholar.org/paper/11d5a532c8241f07198531e1b3f9e416e267d557

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Eric J. Topol

Citations in the corpus

• A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. (2003, background): “(16) reported an increased risk for MI, CVA, or cardiovascular death associated with aspirin resistance as documented by urinary concentrations of 11-dehydro thromboxane B2 in patients with cardiovascular disease or diabetes and one other risk factor for cardiovascular disease.”